Control Bionics Ltd (CBL) - Total Liabilities

Latest as of June 2026: AU$2.73 Million AUD ≈ $1.93 Million USD

Based on the latest financial reports, Control Bionics Ltd (CBL) has total liabilities worth AU$2.73 Million AUD (≈ $1.93 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Control Bionics Ltd (CBL) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Control Bionics Ltd - Total Liabilities Trend (2014–2025)

This chart illustrates how Control Bionics Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Control Bionics Ltd (CBL) total assets.

Control Bionics Ltd Competitors by Total Liabilities

The table below lists competitors of Control Bionics Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Andalan Perkasa Abadi Tbk PT JK:NASA	Indonesia	Rp27.32 Billion
Radiant Innovation TWO:3373	Taiwan	NT$72.50 Million
BonTerra Resources Inc V:BTR	Canada	CA$33.33 Million
NORTH PEAK RESOURCES LTD. F:B9TN	Germany	€1.56 Million
Smartlink Holdings Limited NSE:SMARTLINK	India	Rs639.48 Million
Aguia Resources Ltd AU:AGR	Australia	AU$10.08 Million
KB Autosys Co. Ltd KQ:024120	Korea	₩125.72 Billion
Euroholdings Ltd. NASDAQ:EHLD	USA	$23.77 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Control Bionics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See CBL equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.54	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.43	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.30	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Control Bionics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Control Bionics Ltd (2014–2025)

The table below shows the annual total liabilities of Control Bionics Ltd from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	AU$2.73 Million ≈ $1.93 Million	+0.38%
2024-12-31	AU$2.72 Million ≈ $1.93 Million	-1.28%
2023-12-31	AU$2.76 Million ≈ $1.95 Million	+74.65%
2022-12-31	AU$1.58 Million ≈ $1.12 Million	+4.47%
2021-12-31	AU$1.51 Million ≈ $1.07 Million	+27.07%
2020-12-31	AU$1.19 Million ≈ $842.14K	+207.54%
2019-12-31	AU$387.00K ≈ $273.83K	+2.98%
2018-12-31	AU$375.80K ≈ $265.90K	+74.08%
2017-12-31	AU$215.88K ≈ $152.75K	-99.98%
2016-12-31	AU$876.38 Million ≈ $620.10 Million	+69.81%
2015-12-31	AU$516.09 Million ≈ $365.17 Million	+19.03%
2014-12-31	AU$433.58 Million ≈ $306.78 Million	--

About Control Bionics Ltd

AU:CBL Australia Medical Devices

Market Cap

$23.82 Million

AU$33.67 Million AUD

Market Cap Rank

#24636 Global

#1003 in Australia

Share Price

AU$0.06

Change (1 day)

+3.33%

52-Week Range

AU$0.03 - AU$0.09

All Time High

AU$1.06